Can You Have Mounjaro When Pregnant?

Step 1: understand why Mounjaro is not suitable in pregnancy

The preclinical data are the starting point. Animal studies using tirzepatide at doses broadly in the range of human therapeutic exposure showed reduced fetal growth and other fetal effects. Those findings do not automatically translate to the same outcomes in humans, but they are serious enough that regulators have not licensed the medicine for use during pregnancy, and the SmPC includes a clear recommendation to avoid it. If you are researching whether you can use Mounjaro when pregnant, the short answer from the regulators is that you should not, because human pregnancy data are extremely limited and the uncertainty itself is a reason for caution.

Mechanically, Mounjaro slows gastric emptying and reduces appetite significantly. Adequate caloric and nutrient intake during pregnancy is critical for fetal development. A medicine that makes eating harder adds a layer of risk that is difficult to justify when a safe alternative is to pause treatment. The NHS patient information for tirzepatide is explicit: tell your doctor immediately if you become pregnant, think you may be pregnant, or are planning a pregnancy.

This is not a precaution buried in small print. It is central to safe prescribing, and it is a question our prescribers hear most weeks from people who are planning ahead or who have just had an unexpected positive test. Our guidance on taking Mounjaro when pregnant explains that the right response in both situations is the same: stop the medicine and speak to a clinician.

Step 2: plan your contraception carefully before and during treatment

Because tirzepatide slows gastric emptying, it can reduce how reliably the combined oral contraceptive pill is absorbed, particularly in the early weeks of treatment and after each dose increase. The practical consequence is that the pill may be less effective during those windows.

The NHS England guidance on weight-management injections specifically addresses this: women taking the oral contraceptive pill should use an additional non-oral method (such as condoms) for the first four weeks of Mounjaro treatment and for four weeks after every dose increase. A long-acting reversible contraceptive — the implant, hormonal or copper coil — is not subject to this absorption concern and is often a practical option to discuss with your GP before starting.

If you are planning a pregnancy, the guidance is to stop Mounjaro first and allow a wash-out period before trying to conceive. Your prescriber will advise on the appropriate interval, taking into account your dose and individual circumstances. Do not attempt to conceive while still taking the medicine.

For a broader look at what Mounjaro treatment involves, the Mounjaro treatment overview covers how tirzepatide works and what the licensed use in the UK includes.

Step 3: know what to do if you find out you are pregnant while taking Mounjaro

Stop taking Mounjaro. That is the immediate step. Then contact your GP or midwife as soon as possible, and let your Mounjaro prescriber know too. Our page on Mounjaro when pregnant sets out what to tell your maternity team, including the dose you were taking and roughly how recently you stopped.

The good news is that discovering a pregnancy early and stopping promptly means the period of fetal exposure is short. Your maternity team will assess the situation in the context of your whole medical picture. There is no value in continuing the medicine while you wait for an appointment.

Weight management during and after pregnancy is a legitimate health concern, and it is worth knowing that options exist to revisit treatment once the pregnancy and breastfeeding period are complete. Tirzepatide is also not licensed during breastfeeding, so the timeline for restarting is a conversation for after that period ends. Our free consultation service is there when the time is right, and a prescriber will review your circumstances properly at that point. If you have questions in the meantime, our team is reachable through the contact page.

Who to talk to, and what comes next

Your GP is the first port of call for anything pregnancy-related. If you were prescribed Mounjaro through a private service, that prescriber should also be informed. For questions about your wider weight management after pregnancy, the NICE appraisal of tirzepatide (TA1026) sets out who qualifies for treatment and what the clinical pathway looks like, useful reading for understanding where you might stand once you are ready to revisit the conversation.

Uncertainty about what to do is understandable. These are not small decisions. For anyone asking whether you can take Mounjaro when pregnant, the consistent clinical message is: pause the medicine, speak to a doctor, and plan properly when the time comes. That is also the position of the clinicians at our clinical team, who apply the same standard of care to every consultation, including those that involve questions this sensitive.

If you are currently on treatment and have concerns, the FAQs page covers common questions, and our prescribers are available seven days a week for aftercare support. You can also read our dedicated guidance on Mounjaro and pregnancy for a fuller picture of the clinical considerations involved.